117 related articles for article (PubMed ID: 29648441)
21. Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats.
Jintapattanakit A; Peungvicha P; Sailasuta A; Kissel T; Junyaprasert VB
J Pharm Pharmacol; 2010 May; 62(5):583-91. PubMed ID: 20609059
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of a
Sakuma S; Okamoto M; Matsushita N; Ukawa M; Tomono T; Kawamoto K; Ikeda T; Sakuma S
J Vet Med Sci; 2022 Apr; 84(4):484-493. PubMed ID: 35135938
[TBL] [Abstract][Full Text] [Related]
23. Noninvasive insulin delivery: the great potential of cell-penetrating peptides.
Kamei N; Nielsen EJ; Khafagy el-S; Takeda-Morishita M
Ther Deliv; 2013 Mar; 4(3):315-26. PubMed ID: 23442079
[TBL] [Abstract][Full Text] [Related]
24. The application of mucoadhesive polymers in nasal drug delivery.
Jiang L; Gao L; Wang X; Tang L; Ma J
Drug Dev Ind Pharm; 2010 Mar; 36(3):323-36. PubMed ID: 19735210
[TBL] [Abstract][Full Text] [Related]
25. The influence of AT1002 on the nasal absorption of molecular weight markers and therapeutic agents when co-administered with bioadhesive polymers and an AT1002 antagonist, AT1001.
Song KH; Eddington ND
J Pharm Pharmacol; 2012 Jan; 64(1):30-9. PubMed ID: 22150669
[TBL] [Abstract][Full Text] [Related]
26. Validation of the Absorption-Enhancing Ability of Oligoarginines Grafted onto a Backbone of Hyaluronic Acid through Animal Studies from Rodents to Primates.
Yagi H; Tomono T; Abe K; Tsutsumi Y; Makabe M; Mitsuhashi H; Kimura T; Kobayashi H; Miyata K; Shigeno K; Sakuma S
Mol Pharm; 2024 May; ():. PubMed ID: 38804275
[TBL] [Abstract][Full Text] [Related]
27. Spermined dextran, a cationized polymer, as absorption enhancer for pulmonary application of peptide drugs.
Morimoto K; Fukushi N; Chono S; Seki T; Tabata Y
Pharmazie; 2008 Mar; 63(3):180-4. PubMed ID: 18444505
[TBL] [Abstract][Full Text] [Related]
28. Preparation of exenatide-loaded linear poly(ethylene glycol)-brush poly(l-lysine) block copolymer: potential implications on diabetic nephropathy.
Tong F
Int J Nanomedicine; 2017; 12():4663-4678. PubMed ID: 28721043
[TBL] [Abstract][Full Text] [Related]
29. Amorphous solid dispersion of berberine with absorption enhancer demonstrates a remarkable hypoglycemic effect via improving its bioavailability.
Zhaojie M; Ming Z; Shengnan W; Xiaojia B; Hatch GM; Jingkai G; Li C
Int J Pharm; 2014 Jun; 467(1-2):50-9. PubMed ID: 24607213
[TBL] [Abstract][Full Text] [Related]
30. Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats.
Wang J; Tabata Y; Morimoto K
J Control Release; 2006 Jun; 113(1):31-7. PubMed ID: 16707188
[TBL] [Abstract][Full Text] [Related]
31. Gene delivery to tumor cells by cationic polymeric nanovectors coupled to folic acid and the cell-penetrating peptide octaarginine.
Jiang QY; Lai LH; Shen J; Wang QQ; Xu FJ; Tang GP
Biomaterials; 2011 Oct; 32(29):7253-62. PubMed ID: 21715001
[TBL] [Abstract][Full Text] [Related]
32. Noncovalent Strategy with Cell-Penetrating Peptides to Facilitate the Brain Delivery of Insulin through the Blood-Brain Barrier.
Kamei N; Yamaoka A; Fukuyama Y; Itokazu R; Takeda-Morishita M
Biol Pharm Bull; 2018; 41(4):546-554. PubMed ID: 29607927
[TBL] [Abstract][Full Text] [Related]
33. Transport characteristics of a beta sheet breaker peptide across excised bovine nasal mucosa.
Greimel A; Bernkop-Schnürch A; Del Curto MD; D'Antonio M
Drug Dev Ind Pharm; 2007 Jan; 33(1):71-7. PubMed ID: 17192253
[TBL] [Abstract][Full Text] [Related]
34. One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats.
Khafagy el-S; Kamei N; Nielsen EJ; Nishio R; Takeda-Morishita M
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):736-43. PubMed ID: 24060698
[TBL] [Abstract][Full Text] [Related]
35. Bile Acid as an Effective Absorption Enhancer for Oral Delivery of Epidermal Growth Factor Receptor-Targeted Hybrid Peptide.
Gaowa A; Horibe T; Kohno M; Kawakami K
J Pharm Sci; 2018 May; 107(5):1322-1329. PubMed ID: 29273347
[TBL] [Abstract][Full Text] [Related]
36. Fabrication, Physicochemical Characterization, and Performance Evaluation of Biodegradable Polymeric Microneedle Patch System for Enhanced Transcutaneous Flux of High Molecular Weight Therapeutics.
Shah V; Choudhury BK
AAPS PharmSciTech; 2017 Nov; 18(8):2936-2948. PubMed ID: 28432615
[TBL] [Abstract][Full Text] [Related]
37. A Randomized Trial Comparing the Pharmacokinetics, Safety, and Tolerability of DFN-02, an Intranasal Sumatriptan Spray Containing a Permeation Enhancer, With Intranasal and Subcutaneous Sumatriptan in Healthy Adults.
Munjal S; Gautam A; Offman E; Brand-Schieber E; Allenby K; Fisher DM
Headache; 2016 Oct; 56(9):1455-1465. PubMed ID: 27613076
[TBL] [Abstract][Full Text] [Related]
38. Impact of Sodium
Li Y; Yang D; Zhu C
Molecules; 2018 Nov; 23(11):. PubMed ID: 30453465
[TBL] [Abstract][Full Text] [Related]
39. CriticalSorb: a novel efficient nasal delivery system for human growth hormone based on Solutol HS15.
Illum L; Jordan F; Lewis AL
J Control Release; 2012 Aug; 162(1):194-200. PubMed ID: 22709592
[TBL] [Abstract][Full Text] [Related]
40. The use of low molecular weight protamine to enhance oral absorption of exenatide.
Zhang L; Shi Y; Song Y; Sun X; Zhang X; Sun K; Li Y
Int J Pharm; 2018 Aug; 547(1-2):265-273. PubMed ID: 29800739
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
